-
21.
公开(公告)号:US07790891B2
公开(公告)日:2010-09-07
申请号:US11927009
申请日:2007-10-29
申请人: Pietro Allegrini , Marcello Rasparini , Gabriele Razzetti , Simone Mantegazza , Vittorio Lucchini , Alberto Bologna
发明人: Pietro Allegrini , Marcello Rasparini , Gabriele Razzetti , Simone Mantegazza , Vittorio Lucchini , Alberto Bologna
IPC分类号: C07D471/02 , C07D401/12
CPC分类号: C07D401/12 , C07D471/04
摘要: A process for the preparation of a compound of formula (I), or a salt thereof, wherein Q is ═CR8— or ═N—; and R1-R8 are as herein defined; comprising the reaction of a compound of formula (II), or a salt thereof, wherein Q, R1-R7 are as herein defined; with a reducing agent selected from a trivalent phosphorous compound, an oxidizable solvent and a sulfonic acid chloride; and, if desired, the conversion of a compound of formula (I) to another compound of formula (I) or a salt thereof.
摘要翻译: 一种制备式(I)化合物或其盐的方法,其中Q为= CR8-或= N-; 和R 1 -R 8如本文所定义; 包括式(II)化合物或其盐的反应,其中Q,R 1 -R 7如本文所定义; 与选自三价磷化合物,可氧化溶剂和磺酰氯的还原剂反应; 如果需要,式(I)化合物转化为另一种式(I)化合物或其盐。
-
公开(公告)号:US07750177B2
公开(公告)日:2010-07-06
申请号:US11958778
申请日:2007-12-18
IPC分类号: C07C255/23
CPC分类号: C07C253/30 , C07C255/41
摘要: A process for the preparation of entacapone, in particular as the polymorphic form A, comprising the preparation of a compound of formula (V), wherein R is C1-C6 alkyl, by condensation of N,N-diethyl-cyano-acetamide with a compound of formula (IV), wherein R is C1-C6 alkyl, in the presence of a strong basic agent; the dealkylation of the compound of formula (V) to obtain entacapone, and the crystallization thereof from methyl ethyl ketone is performed to yield the polymorphic form A. The polymorphic form A of entacapone may be used to treat Parkinson's disease and/or to enhance effectiveness of muscle control.
摘要翻译: 恩替卡宾的制备方法,特别是多晶型A,其包括通过N,N-二乙基 - 氰基 - 乙酰胺与一种或多种式I化合物的缩合制备其中R为C1-C6烷基的式(Ⅴ)化合物 式(Ⅳ)化合物,其中R为C1-C6烷基,在强碱性试剂存在下; 进行式(V)化合物的脱烷基化以获得恩他卡朋,并从甲基乙基酮中进行结晶,得到多晶型A.恩他卡朋的多晶型A可用于治疗帕金森病和/或增强有效性 的肌肉控制。
-
公开(公告)号:US20090286996A1
公开(公告)日:2009-11-19
申请号:US12423122
申请日:2009-04-14
IPC分类号: C07D333/58 , C07D333/60 , C07F7/10
CPC分类号: C07D333/56 , C07D333/58 , C07F7/1804 , Y02P20/55
摘要: Process for preparing a compound of formula (I), or a salt thereof, comprising reacting of a compound of formula (II) wherein X and R are as herein defined; with a compound of formula (III) NH2OZ (III) wherein Z is a hydroxy protecting group, in presence of a catalyst, to obtain a compound of formula (IV), or a salt thereof, removing the hydroxyl protecting group to obtain a compound of formula (V), or a salt thereof; converting a compound of formula (V), or a salt thereof, into a compound of formula (I), or a salt thereof; and, if desired, converting a compound of formula (I) into a salt thereof, or vice versa.
摘要翻译: 制备式(I)化合物或其盐的方法,包括其中X和R如本文所定义的式(II)化合物的反应; 与式(III)化合物(其中Z为羟基保护基)在催化剂存在下反应,得到式(Ⅳ)化合物或其盐,除去羟基保护基,得到化合物 式(Ⅴ)化合物或其盐; 将式(Ⅴ)化合物或其盐转化为式(I)化合物或其盐; 如果需要,将式(I)化合物转化为其盐,反之亦然。
-
公开(公告)号:US07385062B2
公开(公告)日:2008-06-10
申请号:US10567492
申请日:2004-07-30
申请人: Graziano Castaldi , Pietro Allegrini , Gabriele Razzetti , Alberto Bologna , Marcello Rasparini , Vittorio Lucchini
发明人: Graziano Castaldi , Pietro Allegrini , Gabriele Razzetti , Alberto Bologna , Marcello Rasparini , Vittorio Lucchini
IPC分类号: C07D257/04
CPC分类号: C07D257/04 , C07F3/02
摘要: A process for the preparation of phenyltetrazole derivatives of formula (II) wherein R and Y are as defined in the disclosure, by direct ortho-metallation of (tetrazol-5-γl)benzene. The compounds of formula (II) are useful intermediates for the preparation of angiotensin II antagonists.
摘要翻译: 制备式(II)的苯基四唑衍生物的方法,其中R和Y如本公开所定义,通过(四唑-5-基)苯的直接邻金属化。 式(II)化合物是制备血管紧张素II拮抗剂的有用的中间体。
-
公开(公告)号:US20070249662A1
公开(公告)日:2007-10-25
申请号:US11737852
申请日:2007-04-20
申请人: Pietro ALLEGRINI , Marcello Rasparini , Gabriele Razzetti , Roberto Rossi , Gianpiero Ventimiglia
发明人: Pietro ALLEGRINI , Marcello Rasparini , Gabriele Razzetti , Roberto Rossi , Gianpiero Ventimiglia
IPC分类号: A61K31/4439 , A61K31/4745 , C07D471/02 , C07D403/02
CPC分类号: C07D471/04 , C07D401/12
摘要: A process for preparation of a compound of formula (I), both as the isomeric mixture and individual isomers, wherein Q is ═CR8— or ═N—; each R1, R2, R3, R4 is independently selected from hydrogen, halogen, hydroxy; nitro; C1-C6 alkyl optionally substituted with hydroxy; alkylthio C1-C6; C1-C6 alkoxy optionally substituted with halogen or C1-C6 alkoxy; phenyl-C1-C6 alkyl; phenyl-C1-C6 alkoxy; and —N(RaRb) wherein each Ra and Rb is independently hydrogen or C1-C6 alkyl or Ra and Rb, taken together with the nitrogen atom they are linked to, form a saturated heterocyclic ring; andeach R5, R6, R7, R8 is independently selected from hydrogen, halogen, hydroxy; C1-C6 alkyl optionally substituted with hydroxy; alkylthio C1-C6; C1-C6 alkoxy optionally substituted with halogen; C1-C6 alkyl-carbonyl, C1-C6 alkoxy-carbonyl, and oxazol-2-yl; comprising converting a compound of formula (IV), to said compound of formula (I), in the presence of a catalyst, if necessary in an organic solvent.
摘要翻译: 制备式(I)化合物的方法,均为异构体混合物和各异构体,其中Q为-CR 8 - 或-N-; 每个R 1,R 2,R 3,R 4,R 4独立地选自氢,卤素,羟基; 硝基 任选被羟基取代的C 1 -C 6烷基; 烷硫基C 1 -C 6烷基; 任选被卤素或C 1 -C 6烷氧基取代的C 1 -C 6烷氧基; 苯基-C 1 -C 6烷基; 苯基-C 1 -C 6烷氧基; 和-N(RaRb),其中每个R a和R b独立地是氢或C 1 -C 6烷基或R a和R b与它们所连接的氮原子一起 形成饱和杂环; 并且每个R 5,R 6,R 7,R 8和R 8独立地选自氢,卤素,羟基 ; 任选被羟基取代的C 1 -C 6烷基; 烷硫基C 1 -C 6烷基; 任选被卤素取代的C 1 -C 6烷氧基; C 1 -C 6烷基 - 羰基,C 1 -C 6烷氧基 - 羰基和恶唑-2(C 1 -C 6) - 基; 包括在催化剂存在下,如果需要在有机溶剂中将式(Ⅳ)化合物转化为所述式(Ⅳ)化合物。
-
公开(公告)号:US20070191439A1
公开(公告)日:2007-08-16
申请号:US10593269
申请日:2005-03-11
IPC分类号: A61K31/428 , C07D277/82
CPC分类号: C07D277/82
摘要: Intermediates useful for the preparation of pramipexole and the use thereof in such synthesis.
摘要翻译: 可用于制备普拉克索的中间体及其在此类合成中的应用。
-
公开(公告)号:US20060270633A1
公开(公告)日:2006-11-30
申请号:US11438392
申请日:2006-05-23
IPC分类号: A61K31/675 , C07F9/547
CPC分类号: C07F9/572
摘要: Novel crystalline form of fosinopril calcium, process for its preparation, pharmaceutical compositions and use thereof in therapy.
摘要翻译: 福辛普利钙的新型结晶形式,其制备方法,药物组合物及其在治疗中的应用。
-
公开(公告)号:US20060183916A1
公开(公告)日:2006-08-17
申请号:US10567492
申请日:2004-07-30
申请人: Graziano Castaldi , Pietro Allegrini , Gabriele Razzetti , Alberto Bologna , Marcello Rasparini , Vittorio Lucchini
发明人: Graziano Castaldi , Pietro Allegrini , Gabriele Razzetti , Alberto Bologna , Marcello Rasparini , Vittorio Lucchini
IPC分类号: C07D403/02
CPC分类号: C07D257/04 , C07F3/02
摘要: A process for the preparation of phenyltetrazole derivatives of formula (II) wherein R and Y are as defined in the disclosure, by direct ortho-metallation of (tetrazol-5-γl)benzene. The compounds of formula (II) are useful intermediates for the preparation of angiotensin II antagonists.
摘要翻译: 制备式(II)的苯基四唑衍生物的方法,其中R和Y如本公开所定义,通过(四唑-5-基)苯的直接邻金属化。 式(II)化合物是制备血管紧张素II拮抗剂的有用的中间体。
-
公开(公告)号:US20050131040A1
公开(公告)日:2005-06-16
申请号:US11010455
申请日:2004-12-14
IPC分类号: A61K31/4178 , A61P9/04 , A61P9/12 , A61P25/22 , A61P27/06 , A61P43/00 , C07D403/10 , A61K31/4184
CPC分类号: C07D403/10
摘要: A process for the preparation of crystalline losartan potassium and crystalline hydrate losartan potassium.
摘要翻译: 一种制备结晶氯沙坦钾和结晶水合氯沙沙坦钾的方法。
-
公开(公告)号:US08461190B2
公开(公告)日:2013-06-11
申请号:US13451651
申请日:2012-04-20
IPC分类号: A61K31/41 , C07D249/00
CPC分类号: C07D249/04
摘要: A process for purifying Rufinamide, comprising: a) providing a dispersion of crude 1-[(2,6-difluorophenyl)methyl]-1H-1,2,3-triazole-4-carboxamide in a solvent mixture containing at least a carboxylic acid, and dissolving it; b) slowly cooling the solution to precipitate Rufinamide crystalline form A; and c) recovering the solid.
摘要翻译: 一种用于纯化Rufinamide的方法,包括:a)提供粗制的1 - [(2,6-二氟苯基)甲基] -1H-1,2,3-三唑-4-甲酰胺在含有至少一种羧酸 酸,并溶解; b)缓慢冷却溶液以沉淀Ruformamide结晶形式A; 和c)回收固体。
-
-
-
-
-
-
-
-
-